Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Collecting samples and data to improve ovarian cancer early detection and prevention

Collects samples and data from people at high risk of, or with, ovarian cancer.

Plain-language title generated from the registry record
Registry title: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Key facts

Where
Chicago, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT00005095, who can take part

Where in United States

  • Robert H. Lurie Comprehensive Cancer Center at Northwestern UniversityChicago, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Northwestern University
Trial code
NCT00005095
Record updated
28 February 2025
Original description
RATIONALE: To improve strategies for detection and prevention of early-stage disease.Read full original descriptionShow less

Northwestern Ovarian Cancer Early Detection & Prevention Program: A Specimen and Data Study

RATIONALE: To improve strategies for detection and prevention of early-stage disease.

PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

DISEASE CHARACTERISTICS:; Meets one of the following criteria:; Considered to be at increased risk for developing ovarian cancer, as defined by one of the following:; Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer; Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor; A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer; Increased risk as deemed by a certified genetic counselor; Undergoing surgery for a gynecologic condition, including any of the following:; Diagnosis of a reproductive cancer; Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts); Highly suspicious adnexal mass; Risk-reducing prophylactic oophorectomy; PATIENT CHARACTERISTICS:; Age; Between the ages of 18 and 80.

ClinicalTrials.gov NCT00005095